C-VGB3 is a selective vascular endothelial growth factor receptor 2 (VEGFR2) antagonist, which inhibits VEGFR2-mediated PI3K/AKT/mTOR and PLCgamma/ERK1/2 signaling pathways. C-VGB3 binds to the extracellular domain of VEGFR2, blocking ligand-receptor interaction and inducing apoptosis in endothelial and tumor cells through both intrinsic (involving Bcl2 family and caspases) and extrinsic (death receptor-mediated) pathways. C-VGB3 is promising for research of angiogenesis-related cancers, such as breast cancer[1][2].
Molecular Weight:
1102.20
Formula:
C43H67N13O17S2
Target:
Akt,Apoptosis,ERK,mTOR,PI3K,VEGFR
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
